Huaxia Eye Hospital Group Co. Ltd. A (301267.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Facilities · China · ISIN CNE100005WL5

Price
15.11 CNY
Market cap
12.69 bn CNY
P/E (2025)
28.80
P/S (2025)
3.07
Dividend yield
1.72 %
Net margin
10.65 %
Return on equity (ROE)
8.08 %
Return on assets (ROA)
5.83 %

Huaxia Eye Hospital Group Co. Ltd. A financials

Fiscal year20242025
Revenue4.03 bn CNY4.14 bn CNY
Gross profit1.78 bn CNY1.79 bn CNY
Operating income635.90 m CNY637.96 m CNY
EBIT608.30 m CNY620.77 m CNY
Net income428.64 m CNY440.65 m CNY
Diluted EPS – continuing operations0.51 CNY0.52 CNY

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Huaxia Eye Hospital Group Co. Ltd. A

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis, treatment, and other ophthalmic medical services for patients with eye disease and myopia; prevention and intervention work to the public. It offers services in the areas of cataract, refractive errors, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, optometry, and ocular trauma, as well as engages in community services. The company was founded in 1997 and is based in Xiamen, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.